Iba1 Antikörper (C-Term)

Produktnummer ABIN2857032

Produktdetails anti-Iba1 Antikörper

Highlights:

• High quality Iba1 Primärantikörper for the detection of IBA1.
• Reliable product with high standard validation data

Target: Iba1 (IBA1) (Ionized Calcium-binding Adapter Molecule 1 (IBA1))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Iba1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Free Floating) (IHC (ff))

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Rabbit Polyclonal antibody to Iba1 (allograft inflammatory factor 1)
Iba1 antibody

Aufreinigung: Purified by antigen-affinity chromatography.

Immunogen: Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Iba1. The exact sequence is proprietary.

Isotyp: IgG

Produktspezifische Information:

Wozu kann der Iba1-Antikörper ABIN2857032 verwendet werden? Dieser polyklonale Kaninchen-Anti-Iba1-Antikörper ist unkonjugiert und eignet sich für den Nachweis von Iba1 / AIF1 (Allograft Inflammatory Factor 1) Antigen in Maus, Mensch und Ratte. Er ist für IHC und Western Blotting validiert.

Welche Validierungsdaten stehen für diesen Iba1-Antikörper zur Verfügung? Es sind 18 Bilder für IHC, Immunfärbung und andere Anwendungen verfügbar. Das Produkt wird in 13 PubMed-Publikationen zitiert und hat 1 unabhängige Kundenvalidierung. Nutzen Sie unseren hochwertigen Iba1-Antikörper, um Iba1 / AIF1 zuverlässig nachzuweisen.

Was ist die Funktion von Iba1 / AIF1? Iba1 ist ein aktinbindendes Protein, das die Kräuselung der Membran und die Aktivierung von RAC verstärkt, die Aktinbindungsaktivität von LCP1 erhöht, Kalzium bindet und eine Rolle bei der RAC-Signalgebung, der Phagozytose, der Makrophagenaktivierung und -funktion, der Proliferation von vaskulären glatten Muskelzellen und T-Lymphozyten, der Lymphozytenmigration und der Gefäßentzündung spielt.

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IHC-Fr: 1:100-1:1000. FACS: 1:50-1:200. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Kommentare:

Positive Control: mouse liver , rat liver

Validation: Orthogonal

Beschränkungen: Nur für Forschungszwecke einsetzbar

Independent Validation (IF)

Validierung #101924 (Immunofluorescence)

by: Centre d'Immunologie de Marseille-Luminy

No.: #101924

Datum: 19.10.2017

Antigen: AIF1

Chargennummer: 39476

Validierte Anwendung: Immunofluorescence

Positivkontrolle: PFA fixed tissue section brain of CX3CR1 GFP mouse. Staining with Iba1 (Wako, 019-19741) and Donkey anti-rabbit Fab’2 AlexaFluor 647

Bewertung: Passed. Immunostaining of mouse brain samples with ABIN2857032 shows specifically the expected staining pattern.

Validierungsbilder

Colocalization (C) of the signals in PFA fixed tissue sections of CX3CR1 GFP mouse brain for the immunostaining of with ABIN2857032 (A) and GFP (B).

Protokoll

Primärantikörper: ABIN2857032

Sekundärantikörper: donkey Fab’2 anti-rabbit A647 conjugated antibody (Jackson Immunoresearch, 711-606-152, lot 128806)

Full Protocol:

• Harvest Brain from 13 weeks old mice in 1x Dulbecco’s phosphate buffered saline (DPBS) (Gibco Life Technologies, 14200-067).
• Fix mouse brain in antigen fix (Diapath, P0014) for 2h at RT.
• Wash tissue in 0.1M pH7.4 phosphate buffer at for 1h at 4°C.
• Dehydrate tissue in 30% sucrose solution ON at 4°C.
• Snap freeze tissue in Tissue Freezing Medium (ElectroMicroscopy Science, 72592-C) at -80°C.
• Cut blocks into 20µm sections using a cryostat (Leica, CM3050 S).
• Transfer sections to a slide.
• Create a hydrophobic barrier on the slide around sections with Dako pen (Dako, S2002, lot 00081640).
• Place slide in a humidified chamber and rehydrate sections in 0.1M TrisHCl pH7.4 for 10min at RT.
• Gently remove buffer by tapping slide.
• Permeabilize tissue in 0.1M TrisHCl pH7.4 containing 2% Triton X-100 (Sigma, batch 015K0039) and 0.5% BSA, for 20min at RT.
• Incubate sections with primary AIF1 (c-term) (antibodies-online, ABIN2857032, Lot 39476) diluted 1:500 in 0.1M TrisHCl pH7.4 containing 2% Triton X-100 (Sigma, batch 015K0039) and 0.5% BSA for 5h at RT. Incubate the negative contrls sections with diluted rabbit serum.
• Wash slides 1x 5min in 0.1M TrisHCl pH7.4.
• Incubate sections with secondary donkey Fab’2 anti-rabbit A647 conjugated antibody (Jackson Immunoresearch, 711-606-152, lot 128806) diluted 1:500 in 0.1M TrisHCl pH7.4 containing 2% Triton X-100 and 0.5% BSA ON at RT.
• Wash slides 1x 5min in 0.1M TrisHCl pH7.4.
• Add approximately 10μl of Slowfade® Gold antifade reagent (Life technologies, 536937, lot 1226836) for each section and mount cover slip.
• Image acquisition on a LSM 880 (Zeiss), 20x magnification, 1000 resolution.

Anmerkungen: Microglial cells in the brain of the CX3CR1 GFP mouse expressing GFP are known to express Aif-1. Immunostaining of the PFA fixed tissue sections with ABIN2857032 showed the expected co-localization of the GFP and Aif-1 signals.

Handhabung

Format: Liquid

Konzentration: 0.06 mg/mL

Buffer: 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Referenzen für anti-Iba1 Antikörper (ABIN2857032)

Kaehler, Seitter, Sandbichler, Tschugg, Obermair, Stefanova, Koschak: "Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases." in: Investigative ophthalmology & visual science, Vol. 61, Issue 6, pp. 12, (2020) (PubMed).

Wahle, Sofranko, Dekkers, Miller, Heusinkveld, Albrecht, Cassee, Schins: "Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer's and vascular disease." in: Neurochemistry international, Vol. 138, pp. 104755, (2020) (PubMed).

Li, Zhang, Yang, Blevins, Norris, Zhao, Huang: "C-terminal binding proteins 1 and 2 in traumatic brain injury-induced inflammation and their inhibition as an approach for anti-inflammatory treatment." in: International journal of biological sciences, Vol. 16, Issue 7, pp. 1107-1120, (2020) (PubMed).

Mondor, Baratin, Lagueyrie, Saro, Henri, Gentek, Suerinck, Kastenmuller, Jiang, Bajénoff: "Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche." in: Immunity, Vol. 50, Issue 6, pp. 1453-1466.e4, (2019) (PubMed).

Olechnowicz, Weivoda, Lwin, Leung, Gooding, Nador, Javaid, Ramasamy, Rao, Edwards, Edwards: "Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment." in: Scientific reports, Vol. 9, Issue 1, pp. 14189, (2019) (PubMed).

Wahl, Solon-Biet, Wang, Wali, Pulpitel, Clark, Raubenheimer, Senior, Sinclair, Cooney, de Cabo, Cogger, Simpson, Le Couteur: "Comparing the Effects of Low-Protein and High-Carbohydrate Diets and Caloric Restriction on Brain Aging in Mice." in: Cell reports, Vol. 25, Issue 8, pp. 2234-2243.e6, (2019) (PubMed).

Huang, Lin, Chen, Chen, Chen, Hsu, Wu: "NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation." in: Journal of neuroinflammation, Vol. 15, Issue 1, pp. 140, (2019) (PubMed).

Götzl, Brendel, Werner, Parhizkar, Sebastian Monasor, Kleinberger, Colombo, Deussing, Wagner, Winkelmann, Diehl-Schmid, Levin, Fellerer, Reifschneider, Bultmann, Bartenstein, Rominger, Tahirovic et al.: "Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. ..." in: EMBO molecular medicine, Vol. 11, Issue 6, (2019) (PubMed).

Lin, Hsuan, Lin, Kuo, Lin, Su, Niu, Chang, Lin: "Human Umbilical Cord Mesenchymal Stem Cells Preserve Adult Newborn Neurons and Reduce Neurological Injury after Cerebral Ischemia by Reducing the Number of Hypertrophic Microglia/Macrophages." in: Cell transplantation, Vol. 26, Issue 11, pp. 1798-1810, (2018) (PubMed).

Zha, Liu, Zhu, Liu, Lu, Xu, Yu, Liu: "A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses." in: Scientific reports, Vol. 6, pp. 36631, (2018) (PubMed).

Zera, Zastre: "Thiamine deficiency activates hypoxia inducible factor-1α to facilitate pro-apoptotic responses in mouse primary astrocytes." in: PLoS ONE, Vol. 12, Issue 10, pp. e0186707, (2017) (PubMed).

Liu, Shi, Huang, Peterson, Wu, Lan, Zhang, He, Woods, Du, Wu, Wang: "Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway." in: Scientific reports, Vol. 6, pp. 19137, (2016) (PubMed).

Wolf, Damme, Stroobants, DHooge, Beck, Hermans-Borgmeyer, Lüllmann-Rauch, Dierks, Lübke: "A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease." in: Disease models & mechanisms, Vol. 9, Issue 9, pp. 1015-28, (2016) (PubMed).

Details zu Iba1

Target: Iba1 (IBA1) (Ionized Calcium-binding Adapter Molecule 1 (IBA1))

Andere Bezeichnung: allograft inflammatory factor 1 (IBA1 Produkte)

Synonyme: AIF-1 antikoerper, IBA1 antikoerper, IRT-1 antikoerper, IRT1 antikoerper, AI607846 antikoerper, D17H6S50E antikoerper, G1 antikoerper, Iba1 antikoerper, Bart1 antikoerper, iba1 antikoerper, mrf-1 antikoerper, fa04b11 antikoerper, wu:fa04b11 antikoerper, AIF antikoerper, AIF1 antikoerper, aif1 antikoerper, allograft inflammatory factor 1 antikoerper, AIF1 antikoerper, Aif1 antikoerper, aif1 antikoerper

Hintergrund: This gene is induced by cytokines and interferon. Its protein product is thought to be involved in negative regulation of growth of vascular smooth muscle cells, which contributes to the anti-inflammatory response to vessel wall trauma. Three transcript variants encoding different isoforms have been found for this gene.

Molekulargewicht: 17 kDa

Gen-ID: 199

UniProt: P55008

Pathways: Smooth Muscle Cell Migration